SBC MEDICAL GROUP HOLDINGS I (SBC) Fundamental Analysis & Valuation

NASDAQ:SBC • US73245B1070

Current stock price

4.53 USD
+0.06 (+1.34%)
At close:
4.6 USD
+0.07 (+1.55%)
After Hours:

This SBC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SBC Profitability Analysis

1.1 Basic Checks

  • In the past year SBC was profitable.
  • In the past year SBC has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SBC reported negative net income in multiple years.
  • In multiple years SBC reported negative operating cash flow during the last 5 years.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

  • SBC's Return On Assets of 13.48% is amongst the best of the industry. SBC outperforms 98.00% of its industry peers.
  • With an excellent Return On Equity value of 17.47%, SBC belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 21.24%, SBC belongs to the top of the industry, outperforming 97.00% of the companies in the same industry.
Industry RankSector Rank
ROA 13.48%
ROE 17.47%
ROIC 21.24%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • The Profit Margin of SBC (24.28%) is better than 100.00% of its industry peers.
  • SBC's Operating Margin of 41.70% is amongst the best of the industry. SBC outperforms 100.00% of its industry peers.
  • SBC has a Gross Margin of 74.09%. This is amongst the best in the industry. SBC outperforms 91.00% of its industry peers.
Industry RankSector Rank
OM 41.7%
PM (TTM) 24.28%
GM 74.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. SBC Health Analysis

2.1 Basic Checks

  • SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for SBC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 6.74 indicates that SBC is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of SBC (6.74) is better than 93.00% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that SBC is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.07, SBC is in the better half of the industry, outperforming 79.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 6.74
ROIC/WACC2.42
WACC8.78%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • SBC has a Current Ratio of 5.10. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.10, SBC belongs to the top of the industry, outperforming 93.00% of the companies in the same industry.
  • SBC has a Quick Ratio of 5.06. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
  • SBC's Quick ratio of 5.06 is amongst the best of the industry. SBC outperforms 93.00% of its industry peers.
Industry RankSector Rank
Current Ratio 5.1
Quick Ratio 5.06
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SBC Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.93%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.28% on average over the next years. This is quite good.
  • Based on estimates for the next years, SBC will show a small growth in Revenue. The Revenue will grow by 3.52% on average per year.
EPS Next Y2.03%
EPS Next 2Y10.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.48%
Revenue Next 2Y5.15%
Revenue Next 3Y3.52%
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

6

4. SBC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.24, the valuation of SBC can be described as reasonable.
  • Based on the Price/Earnings ratio, SBC is valued cheaper than 94.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SBC to the average of the S&P500 Index (26.21), we can say SBC is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.06 indicates a reasonable valuation of SBC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 94.00% of the companies listed in the same industry.
  • SBC is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.24
Fwd PE 9.06
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 95.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.58
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • SBC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.55
PEG (5Y)N/A
EPS Next 2Y10.28%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SBC Dividend Analysis

5.1 Amount

  • No dividends for SBC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SBC Fundamentals: All Metrics, Ratios and Statistics

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (4/6/2026, 8:07:49 PM)

After market: 4.6 +0.07 (+1.55%)

4.53

+0.06 (+1.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-27
Earnings (Next)05-13
Inst Owners1.3%
Inst Owner ChangeN/A
Ins Owners90.38%
Ins Owner Change0%
Market Cap464.69M
Revenue(TTM)N/A
Net Income(TTM)43.32M
Analysts82.86
Price Target8.29 (83%)
Short Float %2.03%
Short Ratio10.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.66%
Min EPS beat(2)-85.33%
Max EPS beat(2)8.01%
EPS beat(4)3
Avg EPS beat(4)5.59%
Min EPS beat(4)-85.33%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.07%
Min Revenue beat(2)-4.16%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.96%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.51%
PT rev (3m)-0.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 9.24
Fwd PE 9.06
P/S 2.6
P/FCF N/A
P/OCF N/A
P/B 1.87
P/tB 2.11
EV/EBITDA 4.58
EPS(TTM)0.49
EY10.82%
EPS(NY)0.5
Fwd EY11.04%
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.74
BVpS2.42
TBVpS2.14
PEG (NY)4.55
PEG (5Y)N/A
Graham Number5.16
Profitability
Industry RankSector Rank
ROA 13.48%
ROE 17.47%
ROCE 26.89%
ROIC 21.24%
ROICexc 39.36%
ROICexgc 48.54%
OM 41.7%
PM (TTM) 24.28%
GM 74.09%
FCFM N/A
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA 0.24
Cap/Depr 69.08%
Cap/Sales 1.14%
Interest Coverage 636.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.1
Quick Ratio 5.06
Altman-Z 6.74
F-Score5
WACC8.78%
ROIC/WACC2.42
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.32%
EPS Next Y2.03%
EPS Next 2Y10.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.93%
Revenue Next Year2.48%
Revenue Next 2Y5.15%
Revenue Next 3Y3.52%
Revenue Next 5YN/A
EBIT growth 1Y14.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1928.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1816.19%
OCF growth 3YN/A
OCF growth 5YN/A

SBC MEDICAL GROUP HOLDINGS I / SBC Fundamental Analysis FAQ

What is the fundamental rating for SBC stock?

ChartMill assigns a fundamental rating of 5 / 10 to SBC.


Can you provide the valuation status for SBC MEDICAL GROUP HOLDINGS I?

ChartMill assigns a valuation rating of 6 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.


Can you provide the profitability details for SBC MEDICAL GROUP HOLDINGS I?

SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SBC MEDICAL GROUP HOLDINGS I (SBC) stock?

The Price/Earnings (PE) ratio for SBC MEDICAL GROUP HOLDINGS I (SBC) is 9.24 and the Price/Book (PB) ratio is 1.87.


Can you provide the expected EPS growth for SBC stock?

The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to grow by 2.03% in the next year.